Client consultation & patch testing Risk Assessment Template

Typical hazards & measures

• Medication masking or amplifying reactions — Screen for antihistamines, corticosteroids, immunosuppressants, isotretinoin and photosensitisers. Adjust timing, select alternatives, or defer where responses may be altered; seek clinician advice for complex cases and document the discussion before proceeding.
• Language and accessibility barriers — Offer translated forms or pictograms, interpreter support where needed, and teach-back to confirm understanding. Allow extra time, provide large-print versions, and ensure clients know how and when to report symptoms or concerns.
• Glove or tape material allergy — Ask about latex and rubber-accelerator sensitivity. Use accelerator-free nitrile gloves and latex-free, hypoallergenic tapes; minimise contact time and check the area at removal. Record materials used and escalate if urticarial or eczematous signs appear.
• Cross-reactivity with related chemicals — Screen for compounds that cross-react with PPD/PTD (e.g., benzocaine, PABA, azo dyes). Provide a written “avoid list,” choose non-cross-reacting options, and record tolerance outcomes to inform future services and product choices.
• Cross-contamination during application — Decant tiny amounts into single-use labelled pots; use fresh applicators and gloves per client. Sanitise hands and touchpoints, keep products separated, discard leftovers, and prevent mixed exposures that could distort outcomes and future service decisions.